{"slideshow_credits": null, "snippet": "The company raised its 2014 profit forecast for the second time since January, again up by a nickel to a range of $5.85 to $5.92 per share, excluding one-time items.", "abstract": "Strong sales of several new drugs lift Johnson & Johnson's second-quarter profit by 13 percent, topping analysts' expectations; J&J reports earnings increased to $4.33 billion, or $1.51 per share, from $3.83 billion, or $1.33 per share, year earlier.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/07/16/business/sales-of-new-drugs-increase-johnson-johnson-profit-13.html", "lead_paragraph": "The company raised its 2014 profit forecast for the second time since January, again up by a nickel to a range of $5.85 to $5.92 per share, excluding one-time items.", "headline": {"main": "Sales of New Drugs Increase Johnson & Johnson Profit 13%", "print_headline": "Sales of New Drugs Increase Johnson & Johnson Profit 13%", "content_kicker": "Business Briefing"}, "_id": "53c5c4b038f0d844fb7d82a1", "word_count": "129", "multimedia": [], "pub_date": "2014-07-16T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Johnson & Johnson", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Company Reports", "name": "subject", "is_major": "N", "rank": "1"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}